Studies have shown that patients with MBC are usually diagnosed at older age and at a more advanced stage and more likely to have estrogen receptor and/or progesterone receptor positive disease compared with female breast cancer (FBC) patients [5,6,7,8,9,10,11]. This evidence concerns the gene PGR and breast cancer.